Skip to content

About
Science
- Overview
- Publications
Pipeline
Investors
Careers
Contact

About
Science
- Overview
- Publications
Pipeline
Investors
Careers
Contact

Press Releases

Choose Year
Search Press Releases

Found 90 Results

May 16, 2022

Surrozen Publishes Article in Cellular and Molecular Gastroenterology and Hepatology Demonstrating that SZN-1326, a Selective Wnt Mimetic,Stimulated Robust Colon Epithelial Regeneration and Ameliorated Colitis in an Acute Model of Inflammatory Bowel Disease (IBD)

May 11, 2022

Surrozen Reports First Quarter 2022 Financial Results

May 5, 2022

Surrozen to Present at the BofA Securities 2022 Healthcare Conference

May 2, 2022

Surrozen Presents Data Supporting Potential of SZN-413 for the Treatment of Diabetic Retinopathy at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

March 24, 2022

Surrozen Reports Fourth Quarter and Full Year 2021 Financial Results

January 10, 2022

Surrozen Announces Key 2022 Milestones for Lead Programs and Acceleration of Research Pipeline

January 5, 2022

Surrozen to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference

November 15, 2021

Surrozen Reports Third Quarter 2021 Financial Results

November 15, 2021

Surrozen to Present at The Piper Sandler 33rd Annual Healthcare Conference

November 15, 2021

Surrozen Presents Data Supporting Potential of SZN-043 at The Liver Meeting 2021,the Annual Meeting of the American Association for the Study of Liver Diseases

«...4 567 8...»

IR Contact

Email: investorinfo@surrozen.com

Email Alerts Sign-Up

Email

Unsubscribe

Loading...

Company

About
Management
Board of Directors
Scientific Advisors
Contact
Careers

Science

Science
Pipeline
Publications

Investors

Overview
News
Events
SEC Filings
Corporate Governance
Stock Information
FAQs

Copyright © 2026 Surrozen. All Rights Reserved

Privacy Policy
FCOI Policy
Accessibility

Scroll to Top